Skip to main content

Articles

Page 133 of 335

  1. Canonical WNT signalling plays a critical role in the regulation of ovarian development; mis-regulation of this key pathway in the adult ovary is associated with subfertility and tumourigenesis. The roles of A...

    Authors: Noha-Ehssan Mohamed, Trevor Hay, Karen R. Reed, Matthew J. Smalley and Alan R. Clarke
    Citation: BMC Cancer 2019 19:677
  2. Chronic lymphocytic leukemia is a malignancy with good prognosis. However, the incidence of secondary tumors increases every year after the diagnosis of chronic lymphotcytic leukemia. One of the induced second...

    Authors: Yinjie Zhu, Yanqing Wang, Zhiyu Qian, Jiahua Pan, Qiang Liu, Baijun Dong and Wei Xue
    Citation: BMC Cancer 2019 19:676
  3. Several new treatment options have become available for pancreatic ductal adenocarcinoma (PDAC), but the support for their use for resectable, borderline resectable and locally advanced PDAC is unclear.

    Authors: Stefan Heinrich, Marc Besselink, Markus Moehler, Jean-Luc van Laethem, Michel Ducreux, Peter Grimminger, Jens Mittler, Hauke Lang, Manfred P. Lutz and Mickael Lesurtel
    Citation: BMC Cancer 2019 19:675
  4. To compare outcomes of high-risk human papilloma virus-related oropharyngeal squamous cell carcinoma (HPV OPSCC) treated with modern radiation treatment (RT) and daily image-guidance, staged with the 7th versus t...

    Authors: Kirsten van Gysen, Mark Stevens, Linxin Guo, Dasantha Jayamanne, David Veivers, Andrew Wignall, Leo Pang, Alexander Guminski, Adrian Lee, George Hruby, Paula Macleod, Alon Taylor and Thomas Eade
    Citation: BMC Cancer 2019 19:674
  5. Despite numerous guidelines, nearly one of two patients with cancer pain remains undertreated, thereby affecting their quality of life. Active patient involvement through Therapeutic Patient Education (TPE) is...

    Authors: Virginie Prevost, Natacha Heutte, Alexandra Leconte, Idlir Licaj, Claire Delorme and Bénédicte Clarisse
    Citation: BMC Cancer 2019 19:673
  6. The neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) are representative blood markers of systemic inflammatory responses. However, the clinical significance of the combination of these mar...

    Authors: Tetsushi Hirahara, Takaaki Arigami, Shigehiro Yanagita, Daisuke Matsushita, Yasuto Uchikado, Yoshiaki Kita, Shinichiro Mori, Ken Sasaki, Itaru Omoto, Hiroshi Kurahara, Kosei Maemura, Keishi Okubo, Yoshikazu Uenosono, Sumiya Ishigami and Shoji Natsugoe
    Citation: BMC Cancer 2019 19:672
  7. Stereotactic radiotherapy is an emerging treatment option for patients with inoperable renal cell carcinoma (RCC). Haemorrhage has not previously been reported to occur as a result of Stereotactic Body Radioth...

    Authors: Liam A. Hilleary, Christopher Wratten, Shankar Siva, Jenna Hilleary and Jarad M. Martin
    Citation: BMC Cancer 2019 19:671
  8. In epithelial cells, tyrosine kinases induce tyrosine phosphorylation and ubiquitination of the E-cadherin complex, which is responsible for the epithelial-mesenchymal transition (EMT). However, the precise me...

    Authors: Yunfeng Zhang, Liangzhang Sun, Xiao Gao, Aining Guo, Yan Diao and Yang Zhao
    Citation: BMC Cancer 2019 19:670
  9. Breast cancer survivors are at risk of developing breast cancer-related lymphedema (BCRL) after surgical treatment, which may have a negative effect on quality of life. The purpose of this study was to investi...

    Authors: Sung Mook Lim, Yujin Han, Seung Il Kim and Hyung Seok Park
    Citation: BMC Cancer 2019 19:669
  10. Recurrent hepatocellular carcinoma (HCC) with a tumor thrombus (TT) extending into the inferior vena cava (IVC)/right atrium (RA) is generally regarded as a terminal-stage condition and there is no worldwide c...

    Authors: Jinrong Lou, Yong Li, Kangning Liang, Yutian Guo, Changlong Song, Lei Chen, Lifang Wang, Fei Wang, Li Zhang, Xia Chen, Xiangdong Xu and Mianshun Pan
    Citation: BMC Cancer 2019 19:668
  11. Cancer is a rapidly evolving, multifactorial disease that accumulates numerous genetic and epigenetic alterations. This results in molecular and phenotypic heterogeneity within the tumor, the complexity of whi...

    Authors: Ana Martín-Pardillos, Ángeles Valls Chiva, Gemma Bande Vargas, Pablo Hurtado Blanco, Roberto Piñeiro Cid, Pedro J. Guijarro, Stefan Hümmer, Eva Bejar Serrano, Aitor Rodriguez-Casanova, Ángel Diaz-Lagares, Josep Castellvi, Samuel Miravet-Verde, Luis Serrano, María Lluch-Senar, Víctor Sebastian, Ana Bribian…
    Citation: BMC Cancer 2019 19:666
  12. Analysis of melanomas for actionable mutations has become the standard of care. Recently, a classification scheme has been proposed that categorizes BRAF mutations based on their mechanisms for activation of the ...

    Authors: Parvez M. Lokhandwala, Li-Hui Tseng, Erika Rodriguez, Gang Zheng, Aparna Pallavajjalla, Christopher D. Gocke, James R. Eshleman and Ming-Tseh Lin
    Citation: BMC Cancer 2019 19:665
  13. A standard therapy for locally advanced rectal cancer (LARC) includes fluoropyrimidine (FP)-based neoadjuvant chemoradiation (nCRT). Previous studies have inconsistently demonstrated that baseline neutrophil- ...

    Authors: Shaan Dudani, Horia Marginean, Patricia A. Tang, Jose G. Monzon, Soundouss Raissouni, Timothy R. Asmis, Rachel A. Goodwin, Joanna Gotfrit, Winson Y. Cheung and Michael M. Vickers
    Citation: BMC Cancer 2019 19:664
  14. An important parameter for survival in patients with esophageal carcinoma is lymph node status. The distribution of lymph node metastases depends on tumor characteristics such as tumor location, histology, inv...

    Authors: Eliza R. C. Hagens, Mark I. van Berge Henegouwen, Johanna W. van Sandick, Miguel A. Cuesta, Donald L. van der Peet, Joos Heisterkamp, Grard A. P. Nieuwenhuijzen, Camiel Rosman, Joris J. G. Scheepers, Meindert N. Sosef, Richard van Hillegersberg, Sjoerd M. Lagarde, Magnus Nilsson, Jari Räsänen, Philippe Nafteux, Piet Pattyn…
    Citation: BMC Cancer 2019 19:662
  15. The physical activity (PA) level of patients undergoing major cancer surgery remains unclear. This pilot study aimed to: (i) Compare preoperative PA level between patients undergoing major cancer surgery and t...

    Authors: Daniel Steffens, Jane M. Young, Michael Solomon, Paula R. Beckenkamp, Cherry Koh, Kenneth Vuong, Matthew A. Brodie and Kim Delbaere
    Citation: BMC Cancer 2019 19:661
  16. Breast cancer is the most common cancer diagnosed in women worldwide. In developed countries, 80–90% of women will survive five years after diagnosis but the transition from hospital-based care to health self-...

    Authors: A. Singleton, S. R. Partridge, R. Raeside, M. Regimbal, K. K. Hyun, C. K. Chow, K. Sherman, E. Elder and J. Redfern
    Citation: BMC Cancer 2019 19:660
  17. In order to maximize later health, there are established components and guidelines for quality follow-up care of breast cancer survivors. However, adherence to quality follow-up in Canada may not be optimal, a...

    Authors: Mary L. McBride, Patti A. Groome, Kathleen Decker, Cynthia Kendell, Li Jiang, Marlo Whitehead, Dongdong Li and Eva Grunfeld
    Citation: BMC Cancer 2019 19:659
  18. Expression of Bcr-Abl in hematopoietic stem cells is sufficient to cause chronic myeloid leukemia (CML) and tyrosine kinase inhibitors (TKI) induce molecular remission in the majority of CML patients. However,...

    Authors: Oliver Herrmann, Maja Kim Kuepper, Marlena Bütow, Ivan G. Costa, Iris Appelmann, Fabian Beier, Tom Luedde, Till Braunschweig, Steffen Koschmieder, Tim H. Brümmendorf and Mirle Schemionek
    Citation: BMC Cancer 2019 19:658
  19. The use of nomograms for prognostication of individual cancer patients has been recommended in order to facilitate precision medicine. However, models for patients with soft tissue sarcomas (STSs) are limited ...

    Authors: Masaya Sekimizu, Koichi Ogura, Hideo Yasunaga, Hiroki Matsui, Sakae Tanaka, Katsunori Inagaki and Akira Kawai
    Citation: BMC Cancer 2019 19:657
  20. Despite an overwhelming body of evidence showing the benefits of physical activity (PA) and exercise for cancer survivors, few survivors meet the exercise oncology guidelines. Moreover, initiating, let alone m...

    Authors: Kirsten N. Adlard, David G. Jenkins, Chloe E. Salisbury, Kate A. Bolam, Sjaan R. Gomersall, Joanne F. Aitken, Suzanne K. Chambers, Jeff C. Dunn, Kerry S. Courneya and Tina L. Skinner
    Citation: BMC Cancer 2019 19:656
  21. Since 2011, a tailored, interdisciplinary head and neck rehabilitation (IHNR) program, covered by the basic healthcare insurance, is offered to advanced head and neck cancer (HNC) patients in the Netherlands C...

    Authors: Ann-Jean C. C. Beck, Ellen Passchier, Valesca P. Retèl, Martijn M. Stuiver, Lisette van der Molen, Willem M. C. Klop, Arash Navran, Wim H. van Harten and Michiel W. M. van den Brekel
    Citation: BMC Cancer 2019 19:655
  22. Yes-associated protein (YAP) plays a crucial role in tumour development and it is the main effector of the Hippo signalling pathway. However, the mechanism underlying YAP downregulation in laryngeal cancer is ...

    Authors: Xiaomin Tang, Yuxuan Sun, Ganglun Wan, Jiaqiang Sun, Jingwu Sun and Chunchen Pan
    Citation: BMC Cancer 2019 19:654
  23. Anthracycline-based chemotherapy is associated with reduced cardiorespiratory fitness in breast cancer patients. High intensity interval training (HIIT) induces greater benefits on cardiorespiratory fitness th...

    Authors: Kyuwan Lee, Irene Kang, Wendy J. Mack, Joanne Mortimer, Fred Sattler, George Salem and Christina M. Dieli-Conwright
    Citation: BMC Cancer 2019 19:653
  24. There is no standard first-line chemotherapy for advanced gastric cancer with severe peritoneal metastasis. Although fluoropyrimidine is often used, its efficacy is limited, and it remains unclear whether comb...

    Authors: Hiroyuki Arai, Satoru Iwasa, Narikazu Boku, Masahiro Kawahira, Hirofumi Yasui, Toshiki Masuishi, Kei Muro, Keiko Minashi, Shuichi Hironaka, Naoki Fukuda, Daisuke Takahari and Takako Eguchi Nakajima
    Citation: BMC Cancer 2019 19:652
  25. Aneuploidy of chromosome 8 in circulating tumor cells (CTCs) has been reported correlates with therapeutic efficacy and prognosis in patients with advanced gastric cancer. However, it is not clear whether it i...

    Authors: Yingjie Chen, Zhipeng Yang, Yingxue Wang, Juandong Wang and Chuanxin Wang
    Citation: BMC Cancer 2019 19:651
  26. DNA aneuploidy has attracted growing interest in clinical practice. Nevertheless, its prognostic value in gastric cancer patients remains controversial. This meta-analysis aims to explore the impact of DNA plo...

    Authors: Jing Xu, Ruolin Zhu, Lulu Fan, Shangqing Ge, Wei Wei, Xiaoqiu Li, Liangshan Da, Zhenya Jia, Zhiyan Zhao, Jie Ning, Jie Da, Wanren Peng, Kangsheng Gu and Guoping Sun
    Citation: BMC Cancer 2019 19:650
  27. Prognostication of patients with colorectal cancer (CRC) currently relies on tumor-node-metastasis (TNM) staging but clinical outcomes of patients of the same histoclinical stage are heterogeneous. It is there...

    Authors: Tung H. Ng, Kathy W. Y. Sham, Chuan M. Xie, Simon S. M. Ng, Ka F. To, Joanna H. M. Tong, Wing Y. Z. Liu, Lin Zhang, Matthew T. V. Chan, William K. K. Wu and Christopher H. K. Cheng
    Citation: BMC Cancer 2019 19:649
  28. Studies have consistently indicated that the majority of individuals meeting the US Prevention Services Task Force guidelines for genetic testing have not had genetic counseling or testing. Despite increased a...

    Authors: Nadine Rayes, Deborah J. Bowen, Tara Coffin, Denise Nebgen, Christine Peterson, Mark F. Munsell, Kathleen Gavin, Rebecca Lechner, Jamie Crase, Deborah Polinsky, Iris Romero, Stephanie V. Blank, Douglas A. Levine, Barbara M. Norquist, Elizabeth M. Swisher and Karen H. Lu
    Citation: BMC Cancer 2019 19:648
  29. Recently, long non-coding RNAs (lncRNAs) were considered as important gene expression regulators involving various biological processes. In this study, we explored the role of lncRNAs in the pathogenesis of ra...

    Authors: Ju-Mei Zhou, Rong Liang, Su-Yu Zhu, Hui Wang, Min Zou, Wei-Jing Zou and Shao-Lin Nie
    Citation: BMC Cancer 2019 19:647
  30. One challenge in caring for cancer patients with incurable disease is the adequate identification of those in need for specialized palliative care (SPC). The study’s aim was to validate an easy to use phenomen...

    Authors: Christoph Ostgathe, Kim N. Wendt, Maria Heckel, Sandra Kurkowski, Carsten Klein, Stefan W. Krause, Florian S. Fuchs, Christian M. Bayer and Stephanie Stiel
    Citation: BMC Cancer 2019 19:646
  31. Ovarian cancer (OC) is the second most frequent gynecological cancer and is associated with a poor prognosis because OC progression is often asymptoma-tic and is detected at a late stage. There remains an urge...

    Authors: Bin Liu, Xiaojie Huang, Yifang Li, Weiguo Liao, Mingyi Li, Yi Liu, Rongrong He, Du Feng, Runzhi Zhu and Hiroshi Kurihara
    Citation: BMC Cancer 2019 19:645
  32. Smoking cessation is a key step towards improving cancer care and outcomes. However, smoking cessation interventions are underprovided in oncology settings. Within Jordan’s only comprehensive oncology center, ...

    Authors: F. I. Hawari, N. A. Obeidat, D. Rimawi and K. Jamal
    Citation: BMC Cancer 2019 19:580
  33. The prognosis of colorectal cancer (CRC) patients can be influenced by genetic mutations and nutritional status. The relationship between these variables is unclear. The objective of the study was to verify th...

    Authors: Mariana Abe Vicente Cavagnari, Tiago Donizetti Silva, Marco Antonio Haddad Pereira, Luísa Jacques Sauer, David Shigueoka, Sarhan Sydney Saad, Katia Barão, Carla Caroline Dias Ribeiro and Nora Manoukian Forones
    Citation: BMC Cancer 2019 19:644
  34. Investigations of colorectal carcinogenesis have mainly focused on examining neoplastic tissue. With our aim of identifying potentially cancer-predisposing molecular compositions, we chose a different approach...

    Authors: Christian Hunnicke Petersen, Badar Mahmood, Christoffer Badsted, Tina Dahlby, Hanne Borger Rasmussen, Mark Berner Hansen and Niels Bindslev
    Citation: BMC Cancer 2019 19:643
  35. Altered expression of microRNAs (miRNAs) is known to contribute to cancer progression. miR-23b and miR-27b, encoded within the same miRNA cluster, are reported to have both tumor suppressive and oncogenic acti...

    Authors: Bethany N. Hannafon, Angela Cai, Cameron L. Calloway, Yi-Fan Xu, Roy Zhang, Kar-Ming Fung and Wei-Qun Ding
    Citation: BMC Cancer 2019 19:642
  36. Delivering widespread BRCA testing to patients with ovarian cancer has been suggested by several scientists, recommended by professional societies and solicited by patients organizations. However, based on the...

    Authors: A. V. Paradiso, M. Digennaro, M. Patruno, S. De Summa, S. Tommasi and I. Berindan-Neagoe
    Citation: BMC Cancer 2019 19:641
  37. In the management of patients with RAS wild-type metastatic colorectal cancer (mCRC), anti-epidermal growth factor receptor (EGFR) therapies have demonstrated a clinical benefit, with longer survival. However, th...

    Authors: Shang-Hung Chen, Hsiang-Lin Tsai, Jeng-Kai Jiang, Yung-Chuan Sung, Ching-Wen Huang, Yu-Min Yeh, Li-Tzong Chen and Jaw-Yuan Wang
    Citation: BMC Cancer 2019 19:640
  38. To evaluate the outcome of patients treated with stereotactic ablative body radiotherapy (SABR) with curative intent for stage I non-small cell lung cancer (NSCLC) with regard to local, regional and distant tu...

    Authors: Emilie Dubaere, Mathilde Goffaux, Marie Wanet, Benoit Bihin, Céline Gheldof, Anne-Sophie Demoulin, Antoine Bolly, Frederique Bustin, Fabrice Duplaquet, Paul-Emile Baugnee, Michel Gustin, Vincent Hers, Fabienne Maisin, Eric Marchand, Sebahat Ocak, Lionel Pirard…
    Citation: BMC Cancer 2019 19:639
  39. The optimal reconstructive method after diaphyseal malignant bone tumor resection remains controversial. This multicenter clinical study was designed to investigate the clinical value and complications of segm...

    Authors: Kai Zheng, Xiu-chun Yu, Yong-cheng Hu, Zeng-wu Shao, Ming Xu, Bai-chuan Wang and Feng Wang
    Citation: BMC Cancer 2019 19:638
  40. Puerto Rico has the highest incidence rate of thyroid cancer (TC) in the Americas and the third highest rate worldwide. The purpose of this study was to compare the burden of TC between the population of PR an...

    Authors: Guillermo Tortolero-Luna, Carlos R. Torres-Cintrón, Mariela Alvarado-Ortiz, Karen J. Ortiz-Ortiz, Diego E. Zavala-Zegarra and Edna Mora-Piñero
    Citation: BMC Cancer 2019 19:637
  41. Muscle-invasive bladder tumors are associated with a high risk of relapse and metastasis even after neoadjuvant chemotherapy and radical cystectomy. Therefore, further therapeutic options are needed and molecu...

    Authors: Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, Andrea Zapater-Moros, Mariana Díaz-Almirón, Jorge M. Arevalillo, María Ferrer-Gómez, Hilario Navarro, Paloma Maín, Enrique Espinosa, Álvaro Pinto and Juan Ángel Fresno Vara
    Citation: BMC Cancer 2019 19:636
  42. Zinc-finger E-box binding homeobox 1 (ZEB-1) plays crucial roles in epithelial-to-mesenchymal transition during tumor carcinogenesis. Published studies have examined the potential value of ZEB-1 as a biomarker...

    Authors: Borong Chen, Baisheng Chen, Zhipeng Zhu, Weipeng Ye, Junjie Zeng, Gang Liu, Shengjie Wang, Jin Gao, Guoxing Xu and Zhengjie Huang
    Citation: BMC Cancer 2019 19:635
  43. Metastasis is a leading cause of breast cancer mortality. The induction of epithelial-to-mesenchymal transition (EMT) and complex oncogenic signaling is a vital step in the evolution of highly metastatic and t...

    Authors: Jia-Hong Chen, Wen-Chien Huang, Oluwaseun Adebayo Bamodu, Peter Mu-Hsin Chang, Tsu-Yi Chao and Tse-Hung Huang
    Citation: BMC Cancer 2019 19:634
  44. The recent implementation of PET with prostate specific membrane antigen (PSMA)-specific radiotracers into the clinical practice has resulted in the significant improvement of accuracy in the detection of pros...

    Authors: Heike Endepols, Agnieszka Morgenroth, Boris D. Zlatopolskiy, Philipp Krapf, Johannes Zischler, Raphael Richarz, Sergio Muñoz Vásquez, Bernd Neumaier and Felix M. Mottaghy
    Citation: BMC Cancer 2019 19:633
  45. A key challenge in phase I trials is maintaining rapid escalation in order to avoid exposing too many patients to sub-therapeutic doses, while preserving safety by limiting the frequency of toxic events. Tradi...

    Authors: Bernard North, Hemant Mahendrakumar Kocher and Peter Sasieni
    Citation: BMC Cancer 2019 19:632
  46. Mammographic density is one of the strongest risk factors for breast cancer. In the general population, mammographic density can be modified by various exposures; whether this is true for women a strong family...

    Authors: Olivia Moran, Andrea Eisen, Rochelle Demsky, Kristina Blackmore, Julia A. Knight, Seema Panchal, Ophira Ginsburg, Kevin Zbuk, Martin Yaffe, Kelly A. Metcalfe, Steven A. Narod and Joanne Kotsopoulos
    Citation: BMC Cancer 2019 19:631
  47. Globally, the incidence and mortality rates of gastric cancer are high, and its poor prognosis is closely related to tumor recurrence and metastasis. Therefore, the molecular mechanisms associated with the mig...

    Authors: Yaoyue Qi, Jing Lv, Shihai Liu, Libin Sun, Yixuan Wang, Hui Li, Weiwei Qi and Wensheng Qiu
    Citation: BMC Cancer 2019 19:630

Featured videos

View featured videos from across the BMC-series journals